Software version 4.44A utilized on the BD MAX System
Published April 26, 2017 · Recall initiated: July 29, 2015
Summary
FDA records medical device Class II recall Z-1864-2017, published April 26, 2017 and initiated July 29, 2015. Recalling firm: BD LIFE SCIENCES; Status: Terminated; Reported quantity: There are 29 US customers and 5 ex-US regions with a BD MAX System running software version 4.44A.; Lot: Catalog number 441916. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The BD MAX System software version 4.44A contains a software anomaly that has the potential to affect some Open System Reagent (OSR) customers utilizing User Defined Protocol (UDP) assays. Customers utilizing only IVD assays are not affected. This anomaly may cause the OSR customer system to incorrectly switch the columns of the truth table on the users display. If the user tries to fix their display data, the display will appear correct however, the database may become incorrect, potentially resulting in incorrect results reporting. BD is able to trace the issue to a limited number of instruments that have software version 4.44A installed. Note that the problem only affects customers that are either creating a new UDP with Result Logic or modifying the Result Logic of an existing UDP.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- BD LIFE SCIENCES
- Distributor
- Worldwide Distribution - US Distribution to the states of : CA, CO, FL, IL, MN, MO, MT, NE, NJ, NY, OH, OR, PA, TX, TN, WA, WI., and to the countries of : Canada, Hong Kong, Taiwan, Turkey and Europe. Federal Government Agency sales/distribution centers or foreign countries VA Fort Harrison and VAMC Austin.
- Lot
- Catalog number 441916
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAvarious polyethylene implants Sports Med Repicci II Tibial Components Product Usage: Partial knee replacementApril 26, 2017
- FDABD Viper LT software, version 3.00HApril 26, 2017
- FDAvarious polyethylene implants Knees Revision Tibial Tray Systems Oxford Partial Knee Orthopedic Salvage SystemApril 26, 2017
- FDA216 Wilson Frame Pads, Model # 5319-37; Used with Radiolucent Wilson Frames, model numbers 5319G and 5321G.April 26, 2017
- FDAvarious polyethylene implants Hips Active Articulation ArComXL Bearings Active Articulation E1 Bearings ArcosApril 26, 2017
- FDALaerdal Compact Suction Unit ¿ 4 under the following labels: 1) 300 ml (3.3 lbs) canister version - CATALOGApril 26, 2017
Questions about this recall
Was Software version 4.44A utilized on the BD MAX System recalled?
Yes. FDA published recall Z-1864-2017 on April 26, 2017. Reported hazard: The BD MAX System software version 4.44A contains a software anomaly that has the potential to affect some Open System Reagent (OSR) customers utilizing User Defined Protocol (UDP) assays. Customers utilizing only IVD assays are not affected. This anomaly may cause the OSR customer system to incorrectly switch the columns of the truth table on the users display. If the user tries to fix their display data, the display will appear correct however, the database may become incorrect, potentially resulting in incorrect results reporting. BD is able to trace the issue to a limited number of instruments that have software version 4.44A installed. Note that the problem only affects customers that are either creating a new UDP with Result Logic or modifying the Result Logic of an existing UDP.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail